A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target Ranges

Background: Reducing glycemic fluctuation is important for optimal diabetes management. This post hoc analysis examined glycemic fluctuations and the proportion of subjects achieving recommended blood glucose targets with the fixed ratio combination of insulin degludec and liraglutide (IDegLira) com...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Technol Ther
Autori principali: King, Allen B., Philis-Tsimikas, Athena, Kilpatrick, Eric S., Langbakke, Irene H., Begtrup, Kamilla, Vilsbøll, Tina
Natura: Artigo
Lingua:Inglês
Pubblicazione: Mary Ann Liebert, Inc. 2017
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5399738/
https://ncbi.nlm.nih.gov/pubmed/28282219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2016.0405
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi